| Karen E Herrick, LPN | |
|
5965 S 900 E, Salt Lake City, UT 84121-1720 | |
| (801) 263-7100 | |
| Not Available |
| Full Name | Karen E Herrick |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 5965 S 900 E, Salt Lake City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386839074 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 6681524-3101 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen E Herrick, LPN 11536 Oakmond Rd, South Jordan, UT 84095-5039 Ph: () - | Karen E Herrick, LPN 5965 S 900 E, Salt Lake City, UT 84121-1720 Ph: (801) 263-7100 |
News Archive
One of the nation's leading cardiovascular medical researchers has issued a call for less aggressive direct-to-consumer advertising and better safety assurances of medications in a special article posted online by JAMA because of its relevance to the recent withdrawals and warning labels on the pain-relieving drugs known as COX-2 inhibitors.
According to the American Cancer Society, our lifetime risk of developing colorectal cancer is about 1 in 20. This March, join Saint Louis University to share the message that prevention can stop colorectal cancer before it starts and help us change these odds.
Two proteins have been identified as prime suspects in the proliferation of breast cancer in a study by an international consortium of researchers from Rice University, the University of North Texas, Denton (UNT); the University of California, San Diego (UCSD); and the Hebrew University of Jerusalem.
Our subconscious motivation to eat is powerfully and dynamically regulated by hormone signals. The gut-derived hormone ghrelin is one such key regulator, promoting appetite through its effects on neurons in a small region of the brain called the hypothalamus.
Helsinn Healthcare S.A. and Zealand Pharma A/S jointly announce that Helsinn has started a Phase IIB clinical dose-finding trial of elsiglutide for the prevention of chemotherapy-induced diarrhea (CID). The first patients out of a planned total of 600 patients with colorectal cancer treated with chemotherapy have been dosed in the trial.
› Verified 5 days ago
Ms. Crystal Renee Cox, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Salt Lake City, UT 84121 Phone: 801-263-7100 | |
Danielle Watson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Salt Lake City, UT 84121 Phone: 801-263-7100 | |
Lorie Lee Pierce, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Salt Lake City, UT 84121 Phone: 801-263-7100 | |
Holly Jackson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2040 Murray Holladay Rd Ste 205, Salt Lake City, UT 84117 Phone: 801-274-0299 | |
Amber Gregg, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 344 E 100 S, Suite 301, Salt Lake City, UT 84111 Phone: 801-322-4257 | |
Melissa Nelson, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5965 S 900 E, Salt Lake City, UT 84121 Phone: 801-263-7100 | |
C Scot Mccusker, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 344 E 100 S Ste 301, Salt Lake City, UT 84111 Phone: 801-428-4257 |